# Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.

> **NCT05340569** · NA · COMPLETED · sponsor: **Laval University** · enrollment: 40 (actual)

## Conditions studied

- Pancreas Cancer, Duct Cell Adenocarcinoma
- Pancreas Adenocarcinoma
- Peritoneal Metastases
- Peritoneal Carcinomatosis

## Interventions

- **DIAGNOSTIC_TEST:** Whole-body diffusion-weighted magnetic resonance imaging

## Key facts

- **NCT ID:** NCT05340569
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-28
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05340569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05340569, "Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05340569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*